Michael Klaber

869 total citations
20 papers, 615 citations indexed

About

Michael Klaber is a scholar working on Immunology, Dermatology and Molecular Biology. According to data from OpenAlex, Michael Klaber has authored 20 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Dermatology and 5 papers in Molecular Biology. Recurrent topics in Michael Klaber's work include Psoriasis: Treatment and Pathogenesis (10 papers), Dermatology and Skin Diseases (7 papers) and Hair Growth and Disorders (2 papers). Michael Klaber is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (10 papers), Dermatology and Skin Diseases (7 papers) and Hair Growth and Disorders (2 papers). Michael Klaber collaborates with scholars based in United Kingdom, Denmark and Finland. Michael Klaber's co-authors include N. DOWNES, P.E. Hutchinson, S. Rogers, C.R. Darley, W.J. Cunliffe, D.D. MUNRO, John R. Gibson, J. M. Best, J E Banatvala and MARCIA SHAW and has published in prestigious journals such as The Lancet, Journal of Clinical Pathology and Thrombosis and Haemostasis.

In The Last Decade

Michael Klaber

18 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Klaber United Kingdom 14 373 336 161 102 67 20 615
C. Buckley United Kingdom 13 277 0.7× 427 1.3× 136 0.8× 119 1.2× 49 0.7× 25 643
M. Sánchez‐Regaña Spain 17 471 1.3× 401 1.2× 186 1.2× 159 1.6× 82 1.2× 43 684
Morad Lahfa France 15 285 0.8× 687 2.0× 136 0.8× 118 1.2× 142 2.1× 21 1.0k
Judit Nyirady United States 18 563 1.5× 524 1.6× 200 1.2× 127 1.2× 126 1.9× 27 949
Fabrizio Martora Italy 17 365 1.0× 568 1.7× 156 1.0× 156 1.5× 72 1.1× 85 836
H Both Netherlands 6 165 0.4× 198 0.6× 281 1.7× 48 0.5× 31 0.5× 8 671
Mark D. Herron United States 9 336 0.9× 269 0.8× 132 0.8× 111 1.1× 88 1.3× 14 622
Anders Johannesson Sweden 11 356 1.0× 346 1.0× 94 0.6× 70 0.7× 132 2.0× 24 692
Darío Kivelevitch United States 13 490 1.3× 254 0.8× 55 0.3× 112 1.1× 110 1.6× 22 643
Alan K. Silverman United States 10 111 0.3× 174 0.5× 61 0.4× 61 0.6× 55 0.8× 13 426

Countries citing papers authored by Michael Klaber

Since Specialization
Citations

This map shows the geographic impact of Michael Klaber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Klaber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Klaber more than expected).

Fields of papers citing papers by Michael Klaber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Klaber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Klaber. The network helps show where Michael Klaber may publish in the future.

Co-authorship network of co-authors of Michael Klaber

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Klaber. A scholar is included among the top collaborators of Michael Klaber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Klaber. Michael Klaber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klaber, Michael, Harvey Baker, & A P Warin. (2006). (4) Porphyria cutanea tarda. British Journal of Dermatology. 95. 28–30.
2.
Chalmers, R.J.G., Brian Kirby, Alwyn Smith, et al.. (2005). Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis. British Journal of Dermatology. 152(3). 444–450. 84 indexed citations
3.
Jong, E.M.G.J. de, J. Lauharanta, Christer T. Jansén, et al.. (2003). The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial. British Journal of Dermatology. 148(2). 318–325. 45 indexed citations
4.
Klaber, Michael. (1997). P120 Long-term safety and efficacy of Calcipotriol scalp solution in scalp psoriasis. Journal of the European Academy of Dermatology and Venereology. 9. S181–S181. 1 indexed citations
5.
Darley, C.R., et al.. (1996). Safety and efficacy of calcipotriol ointment (Dovonex) in treating children with psoriasis vulgaris.. PubMed. 135(3). 390–3. 64 indexed citations
6.
Darley, C.R., et al.. (1996). Safety and efficacy of calcipotriol ointment (Dovonex®) in treating children with psoriasis vulgaris. British Journal of Dermatology. 135(3). 390–393. 13 indexed citations
7.
Darley, C.R., et al.. (1996). Safety and efficacy of calcipotriol ointment (Dovonex®) in treating children with psoriasis vulgaris. British Journal of Dermatology. 135(3). 390–393. 41 indexed citations
8.
Klaber, Michael, P.E. Hutchinson, Knud Kragballe, et al.. (1994). Comparative effects of calcipotriol solution (50 μg/ml) and betamethasone 17-valerate solution (1 mg/ml) in the treatment of scalp psoriasis. British Journal of Dermatology. 131(5). 678–683. 56 indexed citations
9.
Williams, Richard, J.P. VESTEY, Michael J. Tidman, et al.. (1993). A multicentre 12-week open study of a lipid-soluble folate antagonist, piritrexim in severe psoriasis. British Journal of Dermatology. 129(5). 584–589. 8 indexed citations
10.
Berth‐Jones, J., A.C. Chu, W. ALAN DODD, et al.. (1992). A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis. British Journal of Dermatology. 127(3). 266–271. 98 indexed citations
11.
Gibson, John R., Michael Klaber, Susan Harvey, et al.. (1986). Prophylaxis against Herpes labialis with Acyclovir Cream – a Placebo-Controlled Study. Dermatology. 172(2). 104–107. 29 indexed citations
12.
SHAW, MARCIA, Melanie King, J. M. Best, et al.. (1985). Failure of acyclovir cream in treatment of recurrent herpes labialis.. BMJ. 291(6487). 7–9. 67 indexed citations
13.
Klaber, Michael. (1980). Ultra-violet light for psoriasis.. PubMed. 66(2). 36–8. 1 indexed citations
14.
Brown, C. L., et al.. (1979). Rapid cytological diagnosis of basal cell carcinoma of the skin.. Journal of Clinical Pathology. 32(4). 361–367. 22 indexed citations
15.
Klaber, Michael & Harvey Baker. (1978). Analbuminaemia with Cutaneous Angiomata. Journal of the Royal Society of Medicine. 71(1). 67–68. 6 indexed citations
16.
Klaber, Michael & D.D. MUNRO. (1978). Alopecia areata: immunofluorescence and other studies. British Journal of Dermatology. 99(4). 383–386. 37 indexed citations
17.
Klaber, Michael & J S Pegum. (1976). Diffuse Cutaneous Mastocytosis in Mother and Daughter. Proceedings of the Royal Society of Medicine. 69(1). 16–18. 14 indexed citations
18.
Klaber, Michael & D.D. MUNRO. (1974). (8) Malignant lymphoma of the skin treated with bleomycin. British Journal of Dermatology. 91(s10). 48–51.
19.
O’Brien, Jessica, et al.. (1974). Platelet Function Long after Arterial and Venous Thrombosis. Thrombosis and Haemostasis. 31(2). 279–290. 13 indexed citations
20.
O’Brien, John, Sandra Jamieson, M.D. Etherington, & Michael Klaber. (1972). PLATELET FUNCTION IN VENOUS THROMBOSIS AND LOW-DOSAGE HEPARIN. The Lancet. 299(7764). 1302–1305. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Buckley Breakdown of academic impact, for papers by M. Sánchez‐Regaña Breakdown of academic impact, for papers by Morad Lahfa Breakdown of academic impact, for papers by Judit Nyirady Breakdown of academic impact, for papers by Fabrizio Martora Breakdown of academic impact, for papers by H Both Breakdown of academic impact, for papers by Mark D. Herron Breakdown of academic impact, for papers by Anders Johannesson Breakdown of academic impact, for papers by Darío Kivelevitch Breakdown of academic impact, for papers by Alan K. Silverman
Rankless by CCL
2026